Vaccine Packaging Market

What is the Future Outlook for Vaccine Packaging Market in Comparison to Historic Pattern of Growth?

Over the past decade, increasing investment by healthcare institutions and biopharmaceutical firms in research and development of new vaccines and increased government investment in immunization initiatives have given tailwinds to the demand for vaccine packaging. For example, the U.S. government spends billions of dollars per year on R&D of new vaccines to buy and distribute vaccines around the world.

As per World Health Organization (WHO), nearly 80% of vaccine sales are witnessed from the developing countries and emerging markets. The global market is becoming ever more lucrative, given the enormous and growing clinical impact of vaccines.

In addition, the need for vaccine packaging in 2021 and ahead is anticipated to be exceptionally strong with the Covid-19 vaccination programs all around world. Besides this, consumer preferences are largely moving towards preventive vaccination of common diseases such as polio, measles, cancer, and others, thus substantially raising the global demand for packaging of vaccines.

According to FMI’s analysis, Vaccine Packaging Sales Estimated Touch Double Digit Growth during the Forecast Period

According to FMI, the global vaccines sales was stood at US$ 35 Bn in 2015 and it is increased to more than US$ 60 Bn in 2020. These days, vaccine packaging formats such as vials and pre-filled syringes are in high demand, particularly for global vaccination programmes of polio, cancer and more recent Covid-19. Owing to the growing demand from pharmaceutical packaging solutions for vaccines, the market is expected to grow amid pandemic.

The demand for vaccines is expected to rise further in the coming years. Increasing incidence of infectious diseases such as Ebola, hepatitis, influenza, swine flu, tuberculosis, and diphtheria is fuelling the demand for vaccination, in turn creating sales opportunities for vaccine packaging producers. These developments present a positive outlook for growth. FMI expects vaccine packaging market to grow at 13.1% CAGR through 2030.

How is the Global Vaccine Packaging Market Evolving?

Considering the global vaccine consumption, research and development (R&D) initiatives have increased steadily over the last three decades. The number of CAS, A Division of American Chemical Society registered vaccine allied matters has gradually increased and the volume of patent applications has seen similar growth, with more than 148,000 patent applications being released by the end of 2017. The vaccine market shows great commercial promise with such a robust rise in research output across the globe. The global image of vaccine R&D reveals that the U.S., the U.K., China, Japan, France, and Germany are home to some of the major organisations developing new vaccines. Therefore these countries will continue exhibiting high demand for vaccine packaging containers such as vials and ampoules from clinical research centres and biopharmaceutical organizations.

What Are The Most Lucrative Areas of Vaccine Packaging?

Fascinatingly, cancer vaccines are fairly recent therapeutic strategy, but they are now the biggest class of vaccines in terms of substance counts, with this group now accounting for almost half of the new vaccine patents. Manufactures have a great opportunity to look after the segment, as more and more vaccines related to cancer being developed on regular basis by major companies including AstraZeneca plc, Amgen Inc., Bristol-Myers Squibb, Johnson & Johnson, Merck & Co. and many others. These vaccines have to be carefully filled, stored, and transported from coast to coast, for which high-end vials, ampoules and syringes are needed. Besides this, viral and bacterial vaccines are of the two most promising sectors, from which the manufactures of vaccine packaging would get high revenue generation prospects in the coming year.

What is the Impact of Coronavirus Pandemic on Vaccine Packaging Consumption?

According to the WHO, the for vaccines is projected to total 4.8 billion doses in 2019, up by nearly 20 percent from last year due to growth in the Asian and African markets. The recent coronavirus pandemic has pushed the demand for vaccines to a record new high, as people around the world seek out methods of effectively containing the spread of COVID-19.

Governments across various countries are placing colossal orders worth hundreds of millions of dollars and pegging new targets of vials and syringes productions for the manufacturers. As a results, key players are planning to intensify their production rates through enhancing production capabilities and penetrating their products to the untapped markets. 

The manufactures have already started ramping up their production bases for vaccine packaging container to fulfill the global demands.

• In July 2020, SiO2 Materials Science, US-based advanced materials science company, stated that they have successfully scaled their manufacturing capacity to 400 million doses and are on track to hit 1.2 billion capacity before the end of 2020.
• Corning Inc., the U.S. glassmaker based in New York, is tapping a $204 million government contract to accelerate vial manufacturing.
• Stevanato Group has received an order from the global nonprofit Coalition for Epidemic Preparedness Innovations (CEPI) for 100 million vials.

How is Lack of Centralized Procedure for Drug Registration Affecting Vaccine Packaging?

Vaccine packaging manufacturers face the challenge of addressing market dynamics differently for different countries due to the lack of drug centralization. This has been creating a gap between the industry and regulating authorities. Manufacturers operating in the associated industry segments, such as vaccine packaging, face challenges arising from industry rifts in achieving transparency, timeliness, predictability, and quality of the business offering. Further unpredictability in regulations of the pharmaceutical industry might hamper long duration business relations and restrict the scope of income growth and prospects rising from these business relations. Regulations and guidelines subject to pharmaceutical products impact investments in vaccine packaging solutions as pharmaceutical companies invest heavily in intellectual property such as brand names, trademarks, etc.

Country-wise Insights

Strong Pharma Base in U.S. to Support Vaccine Packaging Companies

As per top five country analysis, the U.S. is the leading market for vaccine packaging. It is likely to exhibit strong demand for vaccine packaging over the forecast period. One of the key factors supporting growth is the presence of top pharmaceutical, R&D, and manufacturing companies in the U.S. who especially deals with vaccines for various diseases. Pfizer Inc., Johnson & Johnson, Merck & Co., Inc., AbbVie Inc., Eli Lilly, and Company and many others have their bases U.S. which plays significant role in fuelling the demand for vaccine packaging.

• Pfizer manufactures more than 200 million doses of Pfizer vaccines annually and is one of the largest sterile injectable suppliers in the world, producing more than 1 billion sterile units per year.

This create significant demands for vaccine packaging products and opens new opportunities for players operating in the market.

Strategic Initiatives by the U.K. Government to Augment Growth

The demand for vaccines for coronavirus besides regular diseases is expected to rise considerably across hospitals and healthcare facilities in the U.K. For the same, the government is taking strategic moves, ensuring the supply of vaccines should be regular.

• A pharmaceutical and biotechnology giant Wockhardt has announced a new deal it has inked with the British government to supply millions of doses of various COVID-19 vaccines for the United Kingdom population. As per the agreement, over the next few months, Wockhardt is expected to fill vials with around 30 million doses of the vaccine candidate developed jointly by the University of Oxford and AstraZeneca.
• DWK Life Sciences has announced a supply chain agreement with the UK’s Vaccines Manufacturing and Innovation Centre (VMIC) that will see the company provide primary packaging in the form of borosilicate pharmaceutical glass vials to the organization.

Why Innovation is the Key to Succeed in German Vaccine Packaging Market?

The Federal Statistical Office has reported that healthcare spending in Germany rose by 4% in 2018 from 2017. In 2018, the country’s healthcare spending accounted for 11.7% of the GDP. Additionally, projected health expenditure in Germany exceeds euros 425 bn in 2020, presenting a lucrative landscape for the expansion of the vaccine packaging landscape. Even before the COVID-19 pandemic, health spending in Germany had consistently risen due to the high personal health awareness amongst consumers. Also presence of companies such as SCHOTT AG, and Bormioli Pharma is supporting the expansion in Germany.

In June 2020, SCHOTT delivers pharma vials to package 2 billion doses of COVID-19 vaccines. Also, in 2019 the company invested US$ 1 bnillion for enhancing 50% of pharmaceutical packaging capability. The growth strategies adopted by many such companies are expected to aid the expansion of the target market in Germany.

China’s Entrance to Vaccine Development Market

China is planning to bring affordable vaccines that too following all standards for safety, security and quality. A few multinational corporations from the U.S, the U.K., and Germany have long dominated the global vaccine industry. However companies in China are becoming major producers of vaccines and have begun to sell these vaccines on the global market, competition is expected to rise and prices are set to fall.

• Very recently in January 2021, China’s Sinovac has signed agreement to provide 14 million doses of ready-to-fill vaccines to reduce impact of COVID-19 to Malaysia Pharmaniaga Bhd. Further, Indonesia gave approval to China’s Sinovac Biotech's Covid-19 vaccine.

At the Global Vaccine Summit in June 2020, China pledged a new US$ 20 million commitment to support GAVI’s strategic work for the 2021-2025 period, acknowledging the Alliance's vital work in supplying children around the world with life-saving vaccines.

How big is Opportunity for Vaccine Packaging Sales in India?

As COVID-19 tightened its noose across India, the country exhibited consistently rising demand for vaccines. India is already known to be one of the leading producers of vaccines across the world, presenting highly attractive opportunities for vaccine packaging sales. India’s Serum Institute of India (SII) is also a part of the WHO backed scheme called COVAX, which is intended to help low and middle-income countries secure their access to vaccines.

Download a Comprehensive Report Snapshot

The Indian companies have reported to have begun ramping up vaccine production by adding new facilities or expanding their existing production line. SII, who is the biggest producer of vaccine has reported that it can turn out 60 to 70 million doses of vaccines per month. Likewise, the Bharat Biotech Company has expressed its intent of producing 200 million doses of vaccines in year, creating remarkable opportunities for vaccine packaging producers in India.

Category-wise Insights

Which End-Use Industry Exhibits Maximum Consumption of Vaccine Packaging?

As per FMI analysis, the consumption of vaccine packaging formats such as vials, ampoules and others is more in the diagnostic centers. Although this segment is holding major pie of market share in the global market, it is expected to witness a gain of 260bps of current market share, till next decade. Following this, clinical research organizations have major contribution towards boosting sales of vaccine packaging.  COVID-19 has a significant positive impact on increasing demand for vaccine packaging in these end-use industries.

Which Material is More Preferred for Vaccine Packaging?

Glass remains highly preferred material for vaccine packaging. Glass is not reactive to chemical composition. It is due to its inertness that glass packaging is expected to account for dominant share in the vaccine packaging market. In late 2014, the Health Ministry of India issued draft notification to replace Polyethylene Terephthalate (PET) containers with glass. Several countries around the world have implemented stringent regulations against the use of plastic, which is expected to favor growth in the glass segment

Which is the More Preferred Vaccine Packaging Type?

Future Market Insights predicts that as per packaging type, vials segment to increase by110bps of current market share, by the end of 2030. This is mainly due to increasing drug manufacturing activities, rising consumer’s inclination towards personal health, and government initiatives on various vaccination agendas. On the flip side, ampoules segment is estimated to gain 40 BPS of its market share, by the end of forecast period.

The mass vaccination process would be greatly improved by having the vaccines already in prefilled syringes, certainly the ones that do not require super low temperatures. Fewer expertise and less preparation would be needed and the procedure accelerated by not needing to schedule the vaccine on the front line, probably minimizing interaction time for the patient vaccinator. Likewise, the risk of infection of viral hepatitis through the use of multi-dose vaccine vials and removable needles would be completely removed.

Prefilled syringes are similarly risk reducers, as they have decreased by a factor of 3 the incidence of handling errors and related health threat hazards. Some of the companies operating in the market have already begun capitalizing on this opportunity.

• As COVID-19 demand surges, Becton, Dickinson and Company plans $1.2 bn expansion to boost prefilled syringe output by 50%.
• Retractable Technologies signed two contracts with the U.S. government worth $138 million to supply syringes for a vaccine.

Competitive Landscape

The global market for vaccine packaging is fragmented, with key producers concentrating on offering customized solutions according to customer demand. Leading companies operating in the global market are focusing on optimizing their production, extending their scope globally and offering sustainable solutions for vaccine packaging.

There also is ample focus on innovations and U.S. Food and Drug Administration (FDA) approval among players. Besides aiming at competitive advantage, leading players are focusing on expanding their global footprint as they await approvals from international organizations.

• Johnson & Johnson announced that its phase three study has found its vaccine to be 66-percent effective in preventing COVID-19 overall, and 85-percent effective in preventing severe cases of the disease.
• Novavax has also announced that results from its phase three study in the U.K. show the company’s vaccine is 89.3-percent effective in preventing COVID-19.

Some of the companies operating in the vaccine packaging market are aiming at strategic acquisition of new market entrants precisely who dealt with sustainable vaccine packaging products. High investment in providing vaccine packaging solutions in prefilled syringes are expected to benefit vaccine packaging consumption is multiple ways. For instance, in November 2020, ApiJect Systems Corp. is prepared to start turning out 45 million prefilled syringes a month in the fight against COVID-19.

Some of the leading companies operating in the market are:

• Gerresheimer AG
• West Pharmaceutical Services, Inc.
• Becton, Dickinson & Company
• SCHOTT AG
• SGD S.A.
• Catalent, Inc
• Stevanato Group
• Nipro Corporation
• Piramal Glass Private Limited
• UDG Healthcare plc

*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report.

Scope of the Report

Key Questions Answered in the Report

• Which is the most lucrative market for vaccine packaging?

Europe currently leads the global market for vaccine packaging. Sales in European region expected to be over 1/4^th of total demand by 2021. Within Europe, the demand from Germany is expected to be significantly high.

• Which is the top-selling vaccine packaging type?

Vial is the most preferred vaccine packaging in the market. The demand for vial is expected to increase over the forecast period owing to the higher doses per vial capacity, non-reactive with the contents and among others.

• Which end-user is exhibiting high demand for vaccine packaging?

As per FMI Analysis, diagnostic centers are expected to increase the sales of vaccine packaging market. This is expected to be a result of growing demand for vaccines from diagnostic centers especially now for Coronavirus vaccination programs.

• Which are some of the leading companies offering vaccine packaging?

Some of the leading companies offering vaccine packaging are Amcor Plc, Gerresheimer AG, Stevanato Group, SCHOTT AG, Corning Inc. Pacific Vial Manufacturing Inc., Adelphi Healthcare Packaging, West Pharmaceutical Services, Inc. Nipro Corporation and among others.

Enquiry before Buying

• Is this research conducted by Future Market Insights?

  Yes, the research has been conducted by expert analysts of Future Market Insights through a combination of primary research and secondary research. To know more about how the research was conducted, you can speak to research analyst

• What research methodology is followed by FMI?

  FMI follows a methodology that encompasses demand side assessment of the market, and triangulates the same through supply side analysis. This methodology is based on use of standard market structure, methods and definitions. Request detailed methodology.

• Who are the respondents for primary research?

  FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. For a full list of primary respondents, please reach out to us.

• What are the sources of secondary research?

  FMI conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request. 

• Is a sample of this report available for evaluation?

  Yes, you can request a sample and it will be sent to you through an email.

• How can I buy this report?

  FMI provides a secure online payment system to buy report seamlessly. You can buy the report securely and safely.

Key Segments

Packaging Type

• Vials
• Prefilled Syringes
• Ampoules
• Bags and Pouches

Material

• Plastic
• Glass
• Polystyrene
• Others (Metallic Films)

End-use

• Diagnostic Centres
• Clinical research Organization
• Other Healthcare Units

Region

• North America
• Latin America
• Europe
• Middle East and Africa (MEA)
• East Asia
• South Asia
• Oceania